Hydrochloric Acid

Hydrochloric Acid

SCHEMBL26913

CNO.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8219673 1.00 KDM4E (0.44)
Hydrochloric Acid SCHEMBL28888282 1.00
Hydrochloric Acid SCHEMBL28443243 0.94
SCHEMBL27671 0.93
SCHEMBL8965233 0.93
Methylamine SCHEMBL28332002 0.88
Bromide SCHEMBL8055331 0.86
Ammonia Solution, Strong SCHEMBL6414032 0.86
Iodide SCHEMBL8056908 0.86
SCHEMBL9275448 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2977 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450388-B Composition for removing etching residues, and use method and application thereof 弗萨姆材料美国有限责任公司 2025-03-21 CN claimed
CN-115636788-B Synthesis method of rimonabant N-methyl analogue 合肥工业大学 2025-03-04 CN claimed
CN-118792662-B Electrochemical control deprotection method in enzymatic deoxyribonucleic acid single-chain synthesis and application thereof 苏州硅基生物科技有限公司 2024-12-06 CN claimed
CN-118792662-A Electrochemical control deprotection method in enzymatic deoxyribonucleic acid single-chain synthesis and application thereof 苏州硅基生物科技有限公司 2024-10-18 CN claimed
CN-118459756-A Temperature-sensitive material, glycoconjugate, synthesis method thereof and application of glycoconjugate in sugar solid phase synthesis 南京师范大学 2024-08-09 CN claimed
CN-117965247-B Strong-effect antibacterial laundry detergent and preparation method thereof 东莞市建文洗涤用品有限公司 2024-07-30 CN claimed
CN-117965247-A Strong-effect antibacterial laundry detergent and preparation method thereof 东莞市建文洗涤用品有限公司 2024-05-03 CN claimed
CN-117659575-A Sealing material for electromagnetic valve of pressure difference airtight detection device and preparation method thereof 东莞市博仪自动化科技有限公司 2024-03-08 CN claimed
CN-108794449-B Synthetic method of deuterated fumaric acid vorofacian metabolite 广东东阳光药业有限公司 2023-08-04 CN claimed
CN-115636788-A Synthesis method of rimonabant N-methyl analogue 合肥工业大学 2023-01-24 CN claimed
US-5760243-A Preparation and use of 2-methyl-5-phenylisoxazolidine ALBEMARLE CORPORATION (US) 1998-06-02 US claimed
US-5380869-A Regioselective synthesis of 1,5-diaryl pyrazole anti-inflammatory agents ORTHO PHARMACEUTICAL CORPORATION (US) 1995-01-10 US claimed
EP-0616973-A1 Process for removing excess acid from acidic hydroxylamine salt solution Sachem, Inc. (US) 1994-09-28 EP claimed
US-5281311-A Process for reducing the acid content of hydroxylamine salt solutions and for preparing hydroxylamines from hydroxylamine salts SACHEM, INC. (US) 1994-01-25 US claimed
EP-0577100-A1 Process for reducing the acid content of hydroxylamine salt solutions and for preparing hydroxylamines from hydroxylamine salts SACHEM, INC. (US) 1994-01-05 EP claimed
US-5259934-A Process for removing acid from a hydroxylamine salt solution containing excess acid SACHEM, INC. (US) 1993-11-09 US claimed
EP-0534800-A2 Regioselective synthesis of 1,5-diaryl pyrazole anti-inflammatory agents ORTHO PHARMACEUTICAL CORPORATION (US) 1993-03-31 EP claimed
US-4898952-A Regioselective synthesis of a 1,5-disubstituted pyrazole ORTHO PHARMACEUTICAL CORPORATION (US) 1990-02-06 US claimed
EP-0309953-A1 5-Substituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyl-isoxazolidines FISONS CORPORATION (US) 1989-04-05 EP claimed
EP-0034126-B1 COSMETIC AND DERMATOLOGICAL COMPOSITIONS FOR SHAVING THE SKIN Maggesi, Luigi (IT) 1984-07-04 EP claimed